Similar articles

• Azithromycin for empirical treatment of the nongonococcal urethritis syndrome in men. A randomized double-blind study.

  Stamm WE, Hicks CB, Martin DH, Leone P, Hook EW 3rd, Cooper RH, Cohen MS, Batteiger BE, Workowski K, McCormack WM. Stamm WE, et al. JAMA. 1995 Aug 16;274(7):545-9. JAMA. 1995. PMID: 7629982 Clinical Trial.
• Evolving strategies for management of the nongonococcal urethritis syndrome.

  Schmid GP, Fontanarosa PB. Schmid GP, et al. JAMA. 1995 Aug 16;274(7):577-9. JAMA. 1995. PMID: 7629989 No abstract available.
• A randomized, double-blind study comparing single-dose rifalazil with single-dose azithromycin for the empirical treatment of nongonococcal urethritis in men.

  Stamm WE, Batteiger BE, McCormack WM, Totten PA, Sternlicht A, Kivel NM; Rifalazil Study Group. Stamm WE, et al. Sex Transm Dis. 2007 Aug;34(8):545-52. doi: 10.1097/01.olq.0000253348.44308.8c. Sex Transm Dis. 2007. PMID: 17297383 Clinical Trial.
• Nongonococcal urethritis--a new paradigm.

  Burstein GR, Zenilman JM. Burstein GR, et al. Clin Infect Dis. 1999 Jan;28 Suppl 1:S66-73. doi: 10.1086/514728. Clin Infect Dis. 1999. PMID: 10028111 Review.
• [Progress in researches on the laboratory diagnosis of nongonococcal urethritis].

  Huang Y. Huang Y. Zhonghua Nan Ke Xue. 2004 Jan;10(1):3-8. Zhonghua Nan Ke Xue. 2004. PMID: 14979196 Review. Chinese.